Lecicarbon - smpc

HEALTHCARE PROFESSIONALS

> Take me to the Patient area

Summary of Product Characteristics

Lecicarbon Summary of Product Characteristics

These links will take you to the electronic Medicines Compendium (eMC) website.

By using the links below you will leave the Lecicarbon® website and re-directed to an external site; Aspire Pharma is not responsible for the content on external websites.

Lecicarbon A: View SmPC

Lecicarbon C: View SmPC

For further information please call: 01730 231148, email: [email protected] or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Lecicarbon, please see the abbreviated prescribing information.
LEC1010222E2_JUL2022

Privacy

T&Cs

Modern Slavery Policy

Lecicarbon Summary of Product Characteristics

For further information please call: 01730 231148, email: [email protected] or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148For more information about Lecicarbon, please see the abbreviated prescribing information.LEC1010222E2_JUL2022

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Lecicarbon, please see the abbreviated prescribing information.
LEC1010222E2_JUL2022